Interleukin-2—Induced renal dysfunction in cancer patients is reversed by low-dose dopamine infusion
- 31 July 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 26 (1) , 27-33
- https://doi.org/10.1016/0272-6386(95)90149-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Renal functional reserve: Its significance in normal and salt depletion conditionsKidney International, 1991
- Acute renal failure with preserved renal plasma flow induced by cancer immunotherapyKidney International, 1991
- Prevention of Acute Graft Rejection by the Prostaglandin E1Analogue Misoprostol in Renal-Transplant Recipients Treated with Cyclosporine and PrednisoneNew England Journal of Medicine, 1990
- Prospective Effect of Norepinephrine Infusion in Acute Renal Insufficiency Induced by Interleukin 2 TherapyNephron, 1990
- Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjectsKidney International, 1989
- EFFECTS OF THE PROSTAGLANDIN E1 ANALOG MISOPROSTOL ON CYCLOSPORINE NEPHROTOXICITYTransplantation, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980